- cafead   Feb 28, 2022 at 11:52: AM
via Two patients have died after receiving Celyad Oncology’s off-the-shelf CAR-T cell therapy CYAD-101. The colorectal cancer patients had similar pulmonary findings, prompting Celyad to voluntarily pause the trial while it investigates the events.
article source
article source